Sonova Holding (OTCMKTS:SONVY) Given Consensus Recommendation of “Hold” by Brokerages

Sonova Holding (OTCMKTS:SONVY) has earned a consensus recommendation of “Hold” from the eight ratings firms that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation, one has assigned a buy recommendation and one has given a strong buy recommendation to the company.

A number of brokerages have recently issued reports on SONVY. Royal Bank Of Canada raised shares of Sonova to a “moderate buy” rating in a research report on Tuesday, November 18th. Zacks Research raised Sonova from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th.

Sonova Stock Down 0.2%

SONVY stock opened at $50.55 on Monday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.91 and a current ratio of 1.24. Sonova has a 1 year low of $47.55 and a 1 year high of $68.76. The stock’s fifty day moving average price is $53.11 and its 200-day moving average price is $54.24.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.